PULSE BIOSCIENCES, INC.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
PLSE$58.17+9.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| PULSE BIOSCIENCES, INC. | ||
| Date: May 14, 2026 | By: | /s/ Paul A. LaViolette |
|---|---|---|
| Paul A. LaViolette | ||
| President and Chief Executive Officer (Principal Executive Officer) | ||
| Date: May 14, 2026 | By: | /s/ Jon Skinner |
| Jon Skinner | ||
| Chief Financial Officer (Principal Financial Officer) | ||
| Date: May 14, 2026 | By: | /s/ Steven Weber |
| Steven Weber | ||
| VP of Accounting and Global Corporate Controller (Principal Accounting Officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.